Is tumor size the best predictor of outcome for papillary thyroid cancer?
Y Cheema, D Repplinger, D Elson, H Chen - Annals of surgical oncology, 2006 - Springer
… papillary thyroid cancer. In addition, we sought to establish a tumor size threshold beyond
which papillary cancers … suggest that papillary thyroid tumors should be treated aggressively in …
which papillary cancers … suggest that papillary thyroid tumors should be treated aggressively in …
Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma
CK Chou, KD Yang, FF Chou, CC Huang… - The Journal of …, 2013 - academic.oup.com
… in a BCPAP human papillary thyroid cancer cell line model, … with tumor aggressiveness will
enhance our understanding of the molecular mechanisms involved in tumor aggressiveness …
enhance our understanding of the molecular mechanisms involved in tumor aggressiveness …
Prognostic factors for aggressiveness in subcentimeter papillary thyroid carcinoma: impact of tumor size and lymph node metastases
Y Kayhan, L Azizova, M Yılmaz, M Bakış… - … of Endocrinology and …, 2024 - SciELO Brasil
SciELO - Brasil - Prognostic factors for aggressiveness in subcentimeter papillary thyroid
carcinoma: impact of tumor size and lymph node metastases Prognostic factors for …
carcinoma: impact of tumor size and lymph node metastases Prognostic factors for …
Circulating thyroid-stimulating hormone receptor messenger RNA as a marker of tumor aggressiveness in patients with papillary thyroid microcarcinoma
A Aliyev, M Gupta, C Nasr, B Hatipoglu, M Milas… - Endocrine Practice, 2015 - Elsevier
… thyroid cancer cells, is … papillary thyroid carcinoma PTmC = papillary thyroid microcarcinoma
RT-PCR = real-time reverse transcriptase polymerase chain reaction TSHR mRNA = thyroid-…
RT-PCR = real-time reverse transcriptase polymerase chain reaction TSHR mRNA = thyroid-…
Upregulation of long noncoding RNA LOC100507661 promotes tumor aggressiveness in thyroid cancer
D Kim, WK Lee, S Jeong, MY Seol, H Kim… - Molecular and cellular …, 2016 - Elsevier
… thyroid cancer cells. Lymph node metastasis and BRAF V600E mutations were more frequent
in papillary thyroid cancers … in human thyroid cancer and may play a critical role in thyroid …
in papillary thyroid cancers … in human thyroid cancer and may play a critical role in thyroid …
Serum 25-hydroxyvitamin D level does not affect the aggressiveness and prognosis of papillary thyroid cancer
HY Ahn, YJ Chung, KY Park, BY Cho - Thyroid, 2016 - liebertpub.com
… be associated with the aggressiveness and prognosis of several cancers. This study evaluated
… vitamin D levels on the aggressiveness and prognosis of papillary thyroid cancer (PTC). …
… vitamin D levels on the aggressiveness and prognosis of papillary thyroid cancer (PTC). …
IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma
CK Chou, SY Chi, CH Huang, FF Chou… - The Journal of …, 2016 - academic.oup.com
… Thyroid cancer is the most common endocrine malignancy worldwide, and its prevalence
has increased over time; the most frequent type of thyroid cancer is papillary thyroid carcinoma …
has increased over time; the most frequent type of thyroid cancer is papillary thyroid carcinoma …
Prognostic utility of BRAF mutation in papillary thyroid cancer
M Xing - Molecular and cellular endocrinology, 2010 - Elsevier
Papillary thyroid cancer (PTC) is a common endocrine malignancy that frequently harbors the
oncogenic T1799A BRAF mutation. As a novel prognostic molecular marker, this mutation …
oncogenic T1799A BRAF mutation. As a novel prognostic molecular marker, this mutation …
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
… the aggressiveness of PTC. We previously reported a particularly high prevalence of TERT
… in anaplastic thyroid cancer, poorly differentiated thyroid cancer, and thyroid cancer cell …
… in anaplastic thyroid cancer, poorly differentiated thyroid cancer, and thyroid cancer cell …
The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness
M Sheikh-Ahmad, Y Shalata, J Bejar… - Medicina, 2023 - mdpi.com
… potential predictive factor for disease progression in thyroid cancer and might have a role in
clinical decision-making regarding follow-up and the need for additional treatments for PTC. …
clinical decision-making regarding follow-up and the need for additional treatments for PTC. …